Anaptysbio Inc (ANAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -145,231 | -123,447 | -90,596 | -43,936 | -163,619 |
| Depreciation Amortization | -7,916 | -6,215 | -4,245 | -2,363 | -8,145 |
| Accounts receivable | -33,914 | -5,344 | -2,156 | -238 | -5,432 |
| Other Working Capital | -66,325 | 2,450 | 1,321 | -7,402 | -324 |
| Other Operating Activity | 118,049 | 63,891 | 37,101 | 16,686 | 56,720 |
| Operating Cash Flow | $-135,337 | $-68,665 | $-58,575 | $-37,253 | $-120,800 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -358 | -95 | -60 | -27 | -807 |
| Purchase Of Investment | -380,376 | -259,494 | -208,149 | -58,997 | -303,919 |
| Sale Of Investment | 476,132 | 384,383 | 274,383 | 127,640 | 449,480 |
| Investing Cash Flow | $95,398 | $124,794 | $66,174 | $68,616 | $144,754 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 100,842 | 100,287 | 1,790 | 811 | 2,472 |
| Common Stock Repurchased | -456 | N/A | N/A | N/A | -50,000 |
| Other Financing Activity | 26,668 | -800 | 26,467 | -14,444 | -11,769 |
| Financing Cash Flow | $127,054 | $99,487 | $28,257 | $-13,633 | $-59,297 |
| Beginning Cash Position | 35,965 | 35,965 | 35,965 | 35,965 | 71,308 |
| End Cash Position | 123,080 | 191,581 | 71,821 | 53,695 | 35,965 |
| Net Cash Flow | $87,115 | $155,616 | $35,856 | $17,730 | $-35,343 |
| Free Cash Flow | |||||
| Operating Cash Flow | -135,337 | -68,665 | -58,575 | -37,253 | -120,800 |
| Capital Expenditure | -358 | -95 | -60 | N/A | -807 |
| Free Cash Flow | -135,695 | -68,760 | -58,635 | -37,253 | -121,607 |